Skip to main content

Advertisement

Table 2 Responses to the questionnaire

From: Adherence to oral anticancer chemotherapy: What influences patients’ over or non-adherence? Analysis of the OCTO study through quantitative–qualitative methods

  Responders, N = 38
Cancer treatment
 Already had taken oral chemotherapy 13 (34)
 Knew about the choice between oral/intravenous 8 (21)
 Knew the prescribed dose
  Perfectly well 11 (29)
  Relatively well 22 (58)
  Not well 4 (11)
  Had another treatment for their cancer 10 (26)
  Takes a treatment for side effects related to previous cancer treatment 8 (21)
  Takes a treatment for another condition 21 (55)
Feelings related to capecitabine
 Advantages of the oral route, according to the patient
  Autonomy 22 (58)
  Less anxiety 1 (3)
  Fewer side effects 4 (11)
  No advantages 3 (8)
 Disadvantages of the oral route, according to the patient
  The lack of rigour in drug administration 16 (42)
  Blood test 2 (5)
  Loneliness 2 (5)
  No disadvantages 4 (11)
Relationship with the oncologist
 Explanations given by the oncologist about:
  The treatment (organisation, administration) were insufficient 1 (3)
  The treatment side effects occurrence were insufficient 2 (5)
  Management of the treatment side effects were insufficient 3 (8)
 Questions asked to the oncologist about the first prescription capecitabine
  Side effects 16 (42)
  Loss of hair 2 (5)
  Efficacy 2 (5)
  Treatment duration 2 (5)
Intention to obtain more information elsewhere 13 (34)
  Other clinician 3 (8)
  Internet 10 (26)
Expected changes in daily life due to capecitabine
 Will have to be organised around the treatment administration 26 (69)
 If side effects appear:
  I will stop the treatment 5 (13)
  I will consult a clinician 23 (6A)
  I will continue the treatment whatever 4 (10.5%)
Opinions about adherence
 I think that it is alright to miss a dose 11 (28.9)
 I think that it is alright to stop voluntarily 4 (10.5%)
 I think that missing a dose is dangerous
  Yes 16 (42.1%)
  Did not want to answer the question 16 (42.1%)
  No 6 (15.8%)
  1. The numbers are n (%).